Avantor, Inc. (NYSE:AVTR) Shares Purchased by Legacy Wealth Asset Management LLC

Legacy Wealth Asset Management LLC grew its position in shares of Avantor, Inc. (NYSE:AVTR) by 6.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,363 shares of the company’s stock after acquiring an additional 1,496 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Avantor were worth $513,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of AVTR. Public Employees Retirement System of Ohio increased its position in Avantor by 34.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock worth $8,972,000 after purchasing an additional 88,205 shares in the last quarter. Sound Shore Management Inc. CT purchased a new position in Avantor in the second quarter valued at about $76,412,000. Seven Eight Capital LP acquired a new stake in shares of Avantor in the second quarter valued at about $642,000. New York State Teachers Retirement System purchased a new stake in shares of Avantor during the 3rd quarter valued at about $8,473,000. Finally, Everence Capital Management Inc. acquired a new position in Avantor during the 4th quarter worth approximately $555,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Down 1.9 %

AVTR stock opened at $22.14 on Friday. The firm’s 50-day moving average is $21.46 and its two-hundred day moving average is $23.34. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $15.07 billion, a price-to-earnings ratio of 48.13, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on AVTR. UBS Group reissued a “neutral” rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a research report on Friday. Wells Fargo & Company cut their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Finally, Robert W. Baird decreased their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.